NCT01563042View on ClinicalTrials.gov

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 13, 2012

Primary Completion Date

May 23, 2012

Study Completion Date

May 23, 2012

Conditions
Asthma
Interventions
DRUG

Intravenous (IV) single dose

GSK2434735 administered as a single intervenous dose at the beginning of the study

DRUG

Subcutaneous (SC) single dose

GSK2434735 administered as a single subcutaneous dose at the beginning of the study

Trial Locations (1)

CB2 0QQ

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY